The prevalence, diagnosis and surgical risk factors of spinal tuberculosis in children

Mao-Shui Wang1, Chao Han2, Jun-Li Wang3

  • 1Department of Lab Medicine, Shandong Provincial Chest Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.

Insights

Childhood spinal tuberculosis (TB) in China is a significant public health issue. Early treatment initiation is crucial, as the condition requires more attention and research for effective management.

Area of Science:

  • Pediatric infectious diseases
  • Spinal tuberculosis epidemiology
  • Public health challenges in China

Background:

  • The burden of childhood spinal tuberculosis (TB) in China remains unquantified.
  • Current treatment strategies for pediatric spinal TB lack sufficient evidence.
  • This study addresses the need for data on childhood spinal TB in China.

Purpose of the Study:

  • To estimate the burden of childhood spinal TB in China.
  • To review clinical experiences with pediatric spinal TB.
  • To identify factors influencing treatment and outcomes.

Main Methods:

  • Retrospective analysis of medical records from 2006-2019.
  • Inclusion of pediatric patients (≤15 years) diagnosed with spinal TB.
  • Collection and analysis of demographic, clinical, laboratory, and radiological data.

Main Results:

  • Seventy-two cases of childhood spinal TB were identified, with a prevalence of 4.5% among childhood TB cases.
  • Diagnostic test positivity rates varied: T-SPOT.TB (29.6%), AFB smear (14.3%), mycobacterial culture (23.3%), TB RT-PCR (43.8%), and biopsies (88.5%).
  • The surgical rate was 40.3%, with pulmonary TB being a significant factor associated with the need for surgery (OR=4.000).

Conclusions:

  • Childhood spinal TB is a serious public health concern in China that requires increased attention.
  • Early diagnosis and timely treatment initiation are essential for managing pediatric spinal TB.
  • Further research is needed to develop evidence-based treatment guidelines.
Abstract

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
427
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
744
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
804
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
470
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.2K
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
742